Read the latest insights on emerging CAR T therapies. This personalized treatment has shown promising results in certain types of cancers by harnessing the power of the immune system to fight disease.
Researchers at the University of Pennsylvania have found that CAR T-cell therapy response in recurrent glioblastoma (GBM) is affected by divergent remodeling of the immune system.